MHC class I downregulation in cancer: underlying mechanisms and potential targets for cancer immunotherapy

AM Cornel, IL Mimpen, S Nierkens - Cancers, 2020 - mdpi.com
In recent years, major advances have been made in cancer immunotherapy. This has led to
significant improvement in prognosis of cancer patients, especially in the hematological …

HECT E3 ubiquitin ligases–emerging insights into their biological roles and disease relevance

Y Wang, D Argiles-Castillo, EI Kane… - Journal of cell …, 2020 - journals.biologists.com
ABSTRACT Homologous to E6AP C-terminus (HECT) E3 ubiquitin ligases play a critical role
in various cellular pathways, including but not limited to protein trafficking, subcellular …

ERα, a key target for cancer therapy: A review

Y Liu, H Ma, J Yao - OncoTargets and therapy, 2020 - Taylor & Francis
Estrogen receptor α (ERα) is closely associated with both hormone-dependent and hormone-
independent tumors, and it is also essential for the development of these cancers. The …

The intricate interplay between HIFs, ROS, and the ubiquitin system in the tumor hypoxic microenvironment

Y Wang, X Liu, W Huang, J Liang, Y Chen - Pharmacology & therapeutics, 2022 - Elsevier
Alterations in protein ubiquitination and hypoxia-inducible factor (HIF) signaling both
contribute to tumorigenesis and tumor progression. Ubiquitination is a dynamic process that …

[HTML][HTML] The functions and regulation of Smurfs in cancers

L Fu, CP Cui, X Zhang, L Zhang - Seminars in cancer biology, 2020 - Elsevier
Smad ubiquitination regulatory factor 1 (Smurf1) and Smurf2 are HECT-type E3 ubiquitin
ligases, and both Smurfs were initially identified to regulate Smad protein stability in the TGF …

Smurfs in protein homeostasis, signaling, and cancer

P Koganti, G Levy-Cohen, M Blank - Frontiers in oncology, 2018 - frontiersin.org
Protein ubiquitination is an evolutionary conserved highly-orchestrated enzymatic cascade
essential for normal cellular functions and homeostasis maintenance. This pathway relies on …

Regulation of estrogen signaling and breast cancer proliferation by an ubiquitin ligase TRIM56

M Xue, K Zhang, K Mu, J Xu, H Yang, Y Liu, B Wang… - Oncogenesis, 2019 - nature.com
Breast cancer ranks no. 1 in women cancer worldwide, while 60–70% are estrogen receptor
alpha positive. The estrogen selective modulators, such as tamoxifen, become the effective …

PSMD14 stabilizes estrogen signaling and facilitates breast cancer progression via deubiquitinating ERα

P Yang, X Yang, D Wang, H Yang, Z Li, C Zhang… - Oncogene, 2024 - nature.com
The over-activation of ERα signaling is regarded as the major driver for luminal breast
cancers, which could be effective controlled via selective estrogen receptor modulators …

RNF31 represses cell progression and immune evasion via YAP/PD-L1 suppression in triple negative breast Cancer

H Yang, M Xue, P Su, Y Zhou, X Li, Z Li, Y Xia… - Journal of Experimental …, 2022 - Springer
Background Recently genome-based studies revealed that the abnormality of Hippo
signaling is pervasive in TNBC and played important role in cancer progression. RING finger …

[HTML][HTML] TRIM11 promotes breast cancer cell proliferation by stabilizing estrogen receptor α

J Tang, Y Luo, Z Tian, X Liao, Q Cui, Q Yang, G Wu - Neoplasia, 2020 - Elsevier
Breast cancer is the most commonly diagnosed malignancy in female worldwide, over 70%
of which are estrogen receptor α (ERα) positive. ERα has a crucial role in the initiation and …